Genetic screening in hereditary multiple endocrine neoplasia type 1: Absence of a founder effect among Japanese families

Japanese Journal of Cancer Research

Volumn 87, Issue 9, 1996, Pages 985-994

  Sakurai, Akihiro ^a   Katai, Miyuki ^a   Itakura, Yasunori ^a   Nakajima, Koji ^a   Baba, Kiyoshi ^b,c   Hashizume, Kiyoshi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO KATSURA HOSPITAL   (Japan)

^c MITSUBISHI KYOTO HOSPITAL   (Japan)

Author keywords

Linkage analysis; Loss of heterozygosity; Microsatellite polymorphism; Multiple endocrine neoplasia type 1; Polymerase chain reaction

Indexed keywords

DNA MARKER;

ARTICLE; CHROMOSOME 11; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; FOUNDER EFFECT; GENETIC SCREENING; HETEROZYGOTE; HUMAN; HUMAN CELL; JAPAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL;

EID: 0029840847     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb02130.x     Document Type: Article

References (29)

1. Thakker, R. V. Multiple endocrine neoplasia type 1. In "Endocrinology," ed. L. J. DeGroot, pp. 2815-2831 (1995). W. B. Saunders, Philadelphia.
2. Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y. and Nordenskjöld, M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature, 332, 85-87 (1988).
3. Byström, C., Larsson, C., Lindgren, P. G., Sandelin, K., Falkmer, U., Skogseid, B., Öberg, K., Werner, S. and Nordenskjöld, M. Localization of the MEN1 gene to a small region within chromosome band 11q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA, 87, 1968-1972 (1990).
4. Toda, T., Iida, A., Miwa, T., Nakamura, Y. and Imai, T. Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1). Hum. Mol. Genet., 3, 465-470 (1994).
5. Lagercrantz, J., Larsson, C., Grimmond, S., Skogseid, B., Gobl, A., Friedman, E., Carson, E., Phelan, C., Öberg, K., Nordenskjöld, M., Hayward, N. K. and Weber, G. Candidate genes for multiple endocrine neoplasia type 1. J. Int. Med., 238, 245-248 (1995).
6. Friedman, E., Sakaguchi, K., Bale, A. E., Falchetti, A., Streeten, E., Zimering, M. B., Weinstein, L. S., McBride, W. O., Nakamura, Y., Brandi, M.-L., Norton, J. A., Aurbach, G. D., Spiegel, A. M. and Marx, S. J. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N. Engl. J. Med., 321, 213-218 (1989).
7. Thakker, R. V., Bouloux, P., Wooding, C., Chotai, K., Broad, P. M., Spurr, N. K., Besser, G. M. and O'Riordan, J. L. H. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N. Engl. J. Med. 321, 218-224 (1989).
8. Larsson, C., Shepherd, J., Nakamura, Y., Blomberg, C., Weber, G., Werelius, B., Hayward, N., Teh, B., Tokino, T., Seizinger, B., Skogseid, B., Öberg, K. and Nordenskjöld, M. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J. Clin. Invest., 89, 1344-1349 (1992).
9. Smith, C. M., Wells, S. A. and Gerhard, D. S. Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant. Hum. Genet., 96, 377-387 (1995).
10. Kytölä, S., Leisti, J., Winqvist, R. and Salmela, P. Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers. Hum. Genet., 96, 449-453 (1995).
11. Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J. and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature, 380, 152-154 (1996).
12. Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am. J. Hum. Genet., 54, 1060-1066 (1994).
13. Shepherd, J. J. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognised? Arch. Surg., 126, 935-952 (1991).
14. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. and Weissenbach, J. The 1993-94 Généthon human genetic map. Nat. Genet., 7, 246-339 (1994).
15. Iwasaki, H., Stewart, P. W., Dilley, W. G., Holt, M. S., Steinbrueck, T. D., Wells, S. A. Jr. and Donis-Keller, H. A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95. Genomics, 13, 7-15 (1992).
16. Hauge, X. Y., Evans, G. A. and Litt, M. Dinucleotide repeat polymorphism at the D11S534 locus. Nucleic Acids Res., 19, 4308 (1991).
17. Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68, 820-823 (1971).
18. Lips, C. J. M., Koppeschaar, H. P. F., Berends, M. J. H., Jansen-Schillhorn van Veen, J. M., Struyvenberg, A. and van Vroonhoven, Th. J. M. V. The importance of screening for the MEN 1 syndrome: diagnostic results and clinical management. Henry Ford Hosp. Med. J., 40, 171-172 (1992).
19. Wilkinson, S., Teh, B. T., Davey, K. R., McArdle, J. P., Young, M. and Shepherd, J. J. Cause of death in multiple endocrine neoplasia type 1. Arch. Surg., 128, 683-690 (1993).
20. Skogseid, B. and Öberg, K. Prospective screening in multiple endocrine neoplasia type 1. Henry Ford Hosp. Med. J., 40, 167-170 (1992).
21. Watkins, H. Multiple disease genes cause hypertrophic cardiomyopathy. Br. Heart J., 72, S4-S9 (1994).
22. Carone, F. A., Bacallao, R. and Kanwar, Y. S. Biology of polycystic kidney disease. Lab. Invest., 70, 437-448 (1994).
23. Teh, B. T., Hii, S. I., David, R., Parameswaran, V., Grimmond, S., Walters, M. K., Tan, T. T., Nancarrow, D. J., Chan, S. P., Mennon, J., Larsson, C., Zaini, A., Khalid, B. A. K., Shepherd, J. J., Cameron, D. P. and Hayward, N. K. Multiple endocrine neoplasia type 1 (MEN1) in two Asian families. Hum. Genet., 94, 468-472 (1994).
24. Morelli, A., Falchetti, A., Castello, R., Furlani, L., Tomassetti, P., Tonelli, F., Frilling, A., Serio, M. and Brandi, M. L. Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN1) syndrome. J. Endocrinol. Invest., 18, 329-335 (1995).
25. Yoshimoto, K., Iizuka, M., Iwahana, H., Yamasaki, R., Saito, H., Saito, S. and Sekiya, T. Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with MEN type 1. Cancer Res., 49, 2716-2721 (1989).
26. Yoshimoto, K., Iwahana, H., Kubo, K., Saito, S. and Itakura, M. Allele loss on chromosome 11 in a pituitary tumor from a patient with multiple endocrine neoplasia type 1. Jpn. J. Cancer Res., 82, 886-889 (1991).
27. Thakker, R. V. The molecular genetics of the multiple endocrine neoplasia syndromes. Clin. Endocrinol., 38, 1-14 (1993).
28. Harper, P. S. and Clarke, A. Should we test children for "adult" genetic diseases? Lancet, 335, 1205-1206 (1990).
29. Rona, F. U., Beech, R., Mandalia, S., Donnai, D., Kingston, H., Harris, R., Wilson, O., Axtell, C., Swan, A. V. and Kavanagh, F. The influence of genetic counselling in the era of DNA testing on knowledge, reproductive intentions and psychological wellbeing. Clin. Genet., 46, 198-204 (1994).